References
- McDonald CJ, Calabresi P. Complication of psoriasis. JAMA 224(5), 629 (1973).
- McDonald CJ, Calabresi P. Occlusive vascular disease in psoriatic patients. N. Engl. J. Med. 288(17), 912 (1973).
- Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 296(14), 1735–1741 (2006).
- Greenberg JD, Kremer JM, Curtis JR et al.; CORRONA Investigators. Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann. Rheum. Dis. 70(4), 576–582 (2011).
- Abuabara K, Lee H, Kimball AB. The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study. Br. J. Dermatol. 165(5), 1066–1073 (2011).
- Wu F. The effect of tumor necrosis factor-α inhibitors on the risk of myocardial infarction in patients with psoriasis. Presented at: 69th American Academy of Dermatology. New Orleans, LA, USA, 4–8 February 2011.
- Ryan C, Leonardi CL, Krueger JG et al. Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials. JAMA 306(8), 864–871 (2011).
- Tzellos T, Kyrgidis A, Zouboulis CC. Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials. J. Eur. Acad. Dermatol. Venereol. doi:10.1111/j.1468-3083.2012.04500.x (2012) (Epub ahead of print).
- Mehta NN, Yu Y, Saboury B et al. Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. Arch. Dermatol. 147(9), 1031–1039 (2011).
- Bissonnette R, Tardif JC, Harel F, Pressacco J, Bolduc C, Guertin M. Effects of TNF-α blockade on arterial inflammation assessed by positron emission tomography (PET) in patients with psoriasis. Presented at: 70th Annual Meeting of the American Academy of Dermatology, San Diego, CA, USA, 16–20 March 2012.
- Ol KK, Agachan B, Gormus U, Toptas B, Isbir T. Cox-2 gene polymorphism and IL-6 levels in coronary artery disease. Genet. Mol. Res. 10(2), 810–816 (2011).
- Kleinbongard P, Heusch G, Schulz R. TNF-α in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol. Ther. 127(3), 295–314 (2010).
- Erbel C, Dengler TJ, Wangler S et al. Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability. Basic Res. Cardiol. 106(1), 125–134 (2011).
- Gerszten RE, Tager AM. The monocyte in atherosclerosis – should I stay or should I go now? N. Engl. J. Med. 366(18), 1734–1736 (2012).
- de Cid R, Riveira-Munoz E, Zeeuwen PL et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat. Genet. 41(2), 211–215 (2009).
- Nair RP, Duffin KC, Helms C et al.; Collaborative Association Study of Psoriasis. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat. Genet. 41(2), 199–204 (2009).